Newest by Date
Newest by Title
Oldest by Date
Oldest by Title
6 considerations for value-based contracting for medications
Payments for medications have traditionally been based on volume. As healthcare increasingly shifts ...
Using real-world data to build a learning healthcare system
With more diverse real-world data (RWD), life sciences companies recognize the value of using the right data framework, asking the right questions and engaging expertise.
The pharmaceutical industry’s shift from big data to broad data and AI
From single tasks to enterprise-level challenges, life science companies are using AI to help ...
Clinical trials don’t fail fast enough
The roughly $2.6 billion spent on developing one new drug reflects the fully capitalized costs of studying compounds that ultimately fail to reach
“Connected health” designed for health
Over the years, the life sciences industry has been investing in capturing and analyzing patient health information. Specifically, companies have been creating digital health applications with the goal of improving treatment and care.
I have worked with various flavors of Watson in the last 4 years, and it has taught me a lot about the need to understand bias, both in data and the interpretation of it. In the spirit of transparency, I will be honest about my own bias – my ...
SmartAnalyst Inc. used IBM Explorys clinical data to improve how a company markets its medications
SmartAnalyst and the IBM® Watson Health™ team used the IBM Explorys® data set to study the ...
Generating insights with confidence – agile advanced analytics on longitudinal health records
This webinar replay reviews how the IBM Global Business Services (GBS) team generated actionable ...
When do outcomes-based contracts make sense? The payer perspective
In this opinion brief, Truven Health shares the US payer perspective on outcomes-based contracts...
IBM Explorys offerings for life sciences: cohort analysis
Near-real time data access provides integrated views of the patient journey and clinical practice, enabling life sciences organizations to gain deep insights.
Three principles for bringing augmented intelligence to life sciences
In today’s healthcare system, we are not getting the value for the costs we are spending. It’s a...
IBM and Pfizer to accelerate immuno-oncology research with Watson for Drug Discovery
Watson Health and Pfizer Inc. today announced a collaboration that will utilize IBM Watson for Drug ...
The 5 V’s of big data
by Anil Jain, MD, FACP
Comprehensive Primary Care Plus (CPC+): breaking down the ...
by Donna Daniel
IBM and Pfizer to accelerate immuno-oncology research with ...
by Watson Health